Research and innovation  from the rheumatology experts at Vanderbilt Health

Latest in Rheumatology

Aggressive, Systemic Vasculitis Now Treated with Avacopan

ADVOCATE study demonstrates power of a game-changing therapy to reduce glucocorticoid use by nearly two-thirds.

High T Cell Totals in Plaques Drive Cardio Risks in Lupus

Immunology and cardiovascular systems interact as inflammatory conditions leading to higher atherosclerosis risk.

Clinic Takes Broad View in Grappling with Long COVID

With questions still outnumbering answers, physicians in a long COVID clinic help patients caught in the pandemic kaleidoscope.

Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.

Make a Referral

Nutraceutical in Buckwheat Cleans Up RA Inflammation

2-HOBA hunts down the isolevuglandins responsible for proinflammatory cytokines in rheumatoid arthritis.

Three-decade Review Clarifies Pregnancy Risk in Lupus

Researchers find higher risks of adverse events, underutilized options for mitigation.

Non-coding RNA Signals Synovial Joint Reaction

New evidence reveals a critical regulatory role for non-coding RNAs in inflammatory diseases, including rheumatoid arthritis.

Evolving Best Practices in Pediatric Uveitis Treatment

New studies explore advances in standard and immunosuppressive therapies.

Microbial Small RNAs to Predict Arthritis Outcomes

Acting as biomarkers, microbial sRNAs indicate disease severity and drug responses.
Two physicians reading on a computer screen

Vanderbilt Rheumatology: Sharing Our Latest Innovations

Join our rheumatology experts as they present their latest research and innovations in clinical care.